Qi Yu Chen is a Chinese businessperson who has been at the helm of 24 different companies and currently is Chairman of Shanghai Fosun Health Industrial Holdings Ltd., Co-Chairman for Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Chairman of Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., Chairman for Fosun Industrial Co. Ltd., Chairman at Shanghai Fusheng Pharmaceutical Technology Dev Co., Ltd., Chairman for Fosun Pharma Industrial Pte Ltd. and Chairman at Shanghai Henlius Biotech, Inc. (which are all subsidiaries of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.), Chairman for Shanghai Fosun Pioneering Investment Mgmt Ltd., Chairman at Shanghai Xingshuangjian Medical Investment Mgmt Co., Ltd., Chairman for China Medical Pharmaceutical Material Association, Co-Chairman at New Frontier Health Corp., Chairman of Beijing Xingyuan Innovative Equity Investment Fund Mgmt Co, Director & Vice President at Luz Saúde SA, Chairman for Shanghai Fosun Chemical Pharm Venture Capital Co. Ltd., Chairman for Shanghai Fosun Pharmaceutical Co. Ltd. and Co-Chief Executive Officer & Executive Director at Fosun International Ltd. Mr. Chen is also Chairman for Shanghai Fosun High Technology (Group) Co., Ltd., Chairman for Shanghai Biopharmaceutical Industry Association and Vice Chief Commissioner at China Medicinal Biotech Association and on the board of 47 other companies.

In his past career Mr. Chen was Chairman of Neng Yue Co., Ltd., Chairman at Shanghai Licensed Pharmacist Association and Chairman for Shanghai Pharmaceutical Industry Association.

Qi Yu Chen received an undergraduate degree from Fudan University and an MBA from China Europe International Business School.

- No news -